Icadom
17
3
3
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.9%
1 terminated/withdrawn out of 17 trials
91.7%
+5.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
Role: collaborator
Food Typologies and Multidimensional Phenotyping of Elderly in Auvergne-Rhône-Alpes (Part'AGE)
Role: collaborator
Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes
Role: collaborator
Home Airway Clearance in CF Patients
Role: collaborator
DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial
Role: collaborator
Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)
Role: collaborator
Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes
Role: collaborator
Actimetry Protocol in COPD Patients
Role: collaborator
High-Flow in Hypercapnic Stable COPD Patients
Role: collaborator
Eating Disorders in Type 1 Insulin-dependent Diabetes Patients
Role: lead
Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX )
Role: collaborator
Home Airway Clearance in Patients With Bronchiectasis (Home-Care Bronchiectasis)
Role: collaborator
Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1
Role: collaborator
Lifestyle Intervention in Type 2 Diabetes
Role: lead
Sunrise® a New Medical Device to Diagnose Sleep Apnea Syndrome
Role: collaborator
INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
Role: collaborator
Wearable Noninvasive Positive Pressure Ventilation Device in COPD
Role: lead
All 17 trials loaded